UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determination of reliability criteria for liver stiffness evaluation by transient elastography

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.1182-1191

2013

Volltextzugriff (PDF)

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

Journal of hepatology, 2011-05, Vol.54 (5), p.1011-1019

2011

Volltextzugriff (PDF)

1167 IL-28 GENE VARIATION PREDICTS WHO WILL RESPOND TO INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C IN A FRENCH COHORT

Journal of hepatology, 2010, Vol.52, p.S451-S451

2010

Volltextzugriff (PDF)

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive

Hepatology (Baltimore, Md.), 2012-01, Vol.55 (1), p.58-67

2012

Volltextzugriff (PDF)

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C

Journal of gastroenterology, 2014-03, Vol.49 (3), p.527-537

2014

Volltextzugriff (PDF)

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C

Liver international, 2014-07, Vol.34 (6), p.907-917

2014

Volltextzugriff (PDF)

P0376 : Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study

Journal of hepatology, 2015-04, Vol.62, p.S453-S453

2015

Volltextzugriff (PDF)

P977 UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) TREATED BY TRANSARTERIAL CHEMOEMBOLIZATION (TACE): AFTER TWO SESSIONS, ART OR ABCR SCORES TO GUIDE THE DECISION MAKING PROCESS?

Journal of hepatology, 2014-04, Vol.60 (1), p.S401-S401

2014

Volltextzugriff (PDF)

P976 RETREATMENT WITH TRANSARTERIAL CHEMOEMBOLIZATION (TACE): THE ABCR SCORE, AN AID TO THE DECISION-MAKING PROCESS

Journal of hepatology, 2014-04, Vol.60 (1), p.S400-S400

2014

Volltextzugriff (PDF)

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2012-04, Vol.50 (4), p.693-699

2012

Volltextzugriff (PDF)

Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients

Alimentary pharmacology & therapeutics, 2008-08, Vol.28 (4), p.458-467

2008

Volltextzugriff (PDF)

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy

Clinica chimica acta, 2013-01, Vol.415, p.63-68

2013

Volltextzugriff (PDF)

Optimization and robustness of blood tests for liver fibrosis and cirrhosis

Clinical biochemistry, 2010-11, Vol.43 (16), p.1315-1322

2010

Volltextzugriff (PDF)

Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort

Clinica chimica acta, 2010-01, Vol.411 (1), p.86-91

2010

Volltextzugriff (PDF)

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations

Clinics and research in hepatology and gastroenterology, 2013-11, Vol.37 (5), p.467-472

2013

Volltextzugriff (PDF)

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)

Journal of gastroenterology and hepatology, 2013-02, Vol.28 (2), p.329-334

2013

Volltextzugriff (PDF)

Chronic hepatitis C: future treatment

Clinical pharmacology: advances and applications, 2014-01, Vol.6 (default), p.1-17

2014

Volltextzugriff (PDF)

Onset of coeliac disease and interferon treatment

The Lancet (British edition), 2001-03, Vol.357 (9258), p.803-804

2001

Volltextzugriff (PDF)

Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort

Clinics and research in hepatology and gastroenterology, 2021-01, Vol.45 (1), p.101459-101459, Article 101459

2021

Volltextzugriff (PDF)

Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy

AIDS (London), 2008-08, Vol.22 (13), p.1694-1696

2008

Volltextzugriff (PDF)

Comment conduire des actes de recherche clinique en milieu libéral: de nombreuses difficultés?

Acta endoscopica, 2008-03, Vol.38 (Suppl 1), p.S5-S6

2008

Volltextzugriff (PDF)

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)

Journal of medical virology, 2010-12, Vol.82 (12), p.2027-2031

2010

Volltextzugriff (PDF)

709 A multicentric prospective assessement of non-alcoholic fatty liver disease in french patients with chronic unexplained hypertransaminasemia

Journal of hepatology, 2006-04, Vol.44, p.S261-S261

2006

Volltextzugriff (PDF)

Combining non-invasive methods for assessment of liver fibrosis

Gastroentérologie clinique et biologique, 2008-09, Vol.32 (6), p.73-79

2008

Volltextzugriff (PDF)

L’exploration des anémies d’origine digestive: exploration parla vidéocapsule endoscopique et impact de la prise de médicaments anticoagulants

Endoscopy, 2004, Vol.36 (3)

2004

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(45)
Tagungsberichte
(1)

Sprache

Englisch
(37)
Französisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Middle Aged
(17)
Male
(16)
Female
(15)
Adult
(12)
Life Sciences
(12)
Gastroenterology & Hepatology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Human Health And Pathology
(9)
Infectious Diseases
(9)
Biomarkers - Blood
(8)
Liver Cirrhosis - Diagnosis
(8)
Gastroenterology. Liver. Pancreas. Abdomen
(7)
Hepatitis C
(7)
Hepatitis C Virus
(7)
Liver Cirrhosis
(7)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determination of reliability criteria for liver stiffness evaluation by transient elastography

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

1167 IL-28 GENE VARIATION PREDICTS WHO WILL RESPOND TO INTERFERON-BASED TREATMENT OF CHRONIC HEPATITIS C IN A FRENCH COHORT

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C

P0376 : Stratification of hepatocellular carcinoma. The prognostic score NIACE, an additional aid to the Barcelona Clinic Liver Cancer (BCLC) staging system? Multicenter study

P977 UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC) TREATED BY TRANSARTERIAL CHEMOEMBOLIZATION (TACE): AFTER TWO SESSIONS, ART OR ABCR SCORES TO GUIDE THE DECISION MAKING PROCESS?

P976 RETREATMENT WITH TRANSARTERIAL CHEMOEMBOLIZATION (TACE): THE ABCR SCORE, AN AID TO THE DECISION-MAKING PROCESS

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C

Optimized stepwise combination algorithms of non‐invasive liver fibrosis scores including Hepascore in hepatitis C virus patients

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy

Optimization and robustness of blood tests for liver fibrosis and cirrhosis

Automation of the Hepascore and validation as a biochemical index of liver fibrosis in patients with chronic hepatitis C from the ANRS HC EP 23 Fibrostar cohort

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)

Chronic hepatitis C: future treatment

Onset of coeliac disease and interferon treatment

Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort

Mutation rate in hepatitis C virus NS3 protease is not influenced by HIV-1 protease inhibitor therapy

Comment conduire des actes de recherche clinique en milieu libéral: de nombreuses difficultés?

Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy)

709 A multicentric prospective assessement of non-alcoholic fatty liver disease in french patients with chronic unexplained hypertransaminasemia

Combining non-invasive methods for assessment of liver fibrosis

L’exploration des anémies d’origine digestive: exploration parla vidéocapsule endoscopique et impact de la prise de médicaments anticoagulants

Suchergebnisse filtern